Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194398 · ClinicalTrials.gov registry record
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
A clinical trial of OCS Lung System, sponsored by TransMedics.
- Completed
- Registry status
- 79
- Enrollment target
- 8
- Study locations
NCT04194398 is a study of OCS Lung System that has completed, run by TransMedics. The registered enrollment target is 79 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT04194398, a study of OCS Lung System, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
- 8
- Study locations
Study Summary
Collection of five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System.
Conditions Studied
Interventions
- DEVICE OCS Lung System
Study Locations (8)
California
- University of California at Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
Other
- Hospitals Leuven - Leuven
- Hannover Medical School - Hanover
Arizona
- St. Joseph's Hospital and Medical Center - Phoenix
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-12-31 |
| Est. Completion | 2021-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04194398
The ClinicalTrials.gov registry entry for NCT04194398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with OCS Lung System appearing as the primary indexed condition, and to 1 intervention - of which OCS Lung System is the first listed.
NCT04194398 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Other, Arizona.
Frequently Asked Questions
What is clinical trial NCT04194398 about?
NCT04194398 is a clinical study titled "OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection". Collection of five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System.
What is the current status of trial NCT04194398?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2018-12-31. Estimated completion is 2021-09-30.
What conditions does trial NCT04194398 study?
This clinical trial studies the following conditions: OCS Lung System.
What interventions are being tested in trial NCT04194398?
The interventions under investigation include: OCS Lung System (DEVICE).
Who is sponsoring clinical trial NCT04194398?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04194398 being conducted?
This trial has 8 study locations across Arizona, California, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.